-
-
MUCINEX D (Brand for MUCUS RELIEF D)
- QTY 36
- 600MG-60MG
- Tablet ER 12H
- Near 77381
GUAIFENESIN; PSEUDOEPHEDRINE (gwye FEN e sin; soo doe e FED rin) treats the symptoms of the common cold, allergies, or flu. It works by decreasing a runny or stuffy nose and loosening mucus. It is a combination of a decongestant and an expectorant.
Change Location
Set Price Drop Alert for:
MUCINEX D (Brand for MUCUS RELIEF D)
- QTY 36
- 600MG-60MG
- Tablet ER 12H
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
MUCINEX D (Brand for MUCUS RELIEF D)
- QTY 36
- 600MG-60MG
- Tablet ER 12H
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Generic Available
Medicine Chest
MUCINEX D (Brand for MUCUS RELIEF D) Lifestyle Interactions
-
Mycophenolate Mofetil 500mg, Oral tablet
• Interaction: Food• Severity: Mild• Notes for Consumers: Do not take Mycophenolate with Food unless instructed otherwise. Take Mycophenolate either 1 hour before or 2 hours after eating. Food can vary the amount of Mycophenolate in your body at different times.• Notes for Professionals: Administration of mycophenolate with food can affect absorption of the drug. The extent of absorption is not affected, but the maximum serum concentration is lowered as compared with the fasting state. Patients need to be told to take mycophenolate either 1 hour before or 2 hours after eating.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
